Collard Craig A 4
4 · HERON THERAPEUTICS, INC. /DE/ · Filed Apr 22, 2025
Insider Transaction Report
Form 4
Collard Craig A
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2025-04-19+13,796→ 391,163 total - Exercise/Conversion
Restricted Stock Units
2025-04-19−13,796→ 151,766 totalExercise: $0.00→ Common Stock (13,796 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024).